BriaCell Therapeutics Corp. — Proxy Solicitation & Information Statement 2025

Jan 3, 2025

BriaCell
Suite 300 – 235 15th Street,
West Vancouver, BC, V7T 2X1
www.briacell.com

Date: January 3, 2025

To: All Canadian Securities Regulatory Authorities

Amended – See Highlighted

Subject: BRIACELL THERAPEUTICS CORP.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject

Issuer:

Meeting Type: Annual General Meeting
Record Date for Notice of Meeting: December 09, 2024
Record Date for Voting (if applicable): December 09, 2024
Beneficial Ownership Determination Date: December 09, 2024
Meeting Date: February 05, 2025
Meeting Location (if available) : Toronto, ON
Issuer sending proxy related materials directly to NOBO: Yes
Issuer paying for delivery to OBO: Yes

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders: No
NAA for Registered Holders: No

Voting Security Details:

Description	CUSIP Number	ISIN
COMMON	107930109	CA1079301091

Sincerely,

BRIACELL THERAPEUTICS CORP.